SHIFT Newsroom · GLOBAL
Tirzepatide Investigated for Obesity-Driven Endometrial Cancer
A clinical trial is underway to explore the potential of Tirzepatide in treating endometrial cancer linked to obesity.
A clinical trial is investigating the use of Tirzepatide in treating endometrial cancer linked to obesity. The trial, registered on ClinicalTrials.gov, aims to explore the efficacy of Tirzepatide in this patient population.
What this means in the UK
This trial may have implications for UK patients with obesity-driven endometrial cancer, potentially offering a new treatment option in the future.
Known facts
- A clinical trial titled 'Tirzepatide in Obesity-Driven Endometrial Cancer' is registered on ClinicalTrials.gov